Public Calendar: February 10-16, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date: 02/12/2019
Location: Washington, DC
Subject: Dr. Nathan Davis Awards for Outstanding Government Service
FDA Participant/Group: CARLYLE MCWILLIAMS;
Non FDA Participant/Group: Government, academia, industry, and other invited guests
Official Name: Patrizia Cavazzoni, M.D., (Acting), Deputy Director for Operation, CDER
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 02/13/2019
Location: Dallas, TX
Subject: Romaine Task Force Produce Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the Romaine Task Force
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Keagan Lenihan, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 02/11/2019
Location: Alexandria, VA
Subject: Navigating the Nexus between Regulatory Science Policy and Entrepreneurship Biofabrication/Biomanufacturing Workshop
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the academic researchers association, administrators, entrepreneurs, industry leaders, regulatory and policy representatives, investors, and funding agency officers
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 02/13/2019
Location: Silver Spring, MD
Subject: Diabetic Medical Devices and Neuromodulation Closed Loop Technology
FDA Participant/Group: TIMOTHY STENZEL; PAMELA SCOTT; DONALD ST PIERRE; TIMOTHY MARJENIN;
Non FDA Participant/Group: Alejandro Galindo, Ali Dianaty, David Breiter, Geoff Martha, Hooman Hakami, Luann Pendy, Mike Coyle, Nicole Stanchina, Patrick Johnson, Ricahrd Kuntz, Robert Raike, Robert Vigersky, Steven Goetz, Tim Samsel (Medtronic);
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date: 02/11/2019
Location: Washington, DC
Subject: 8th Annual Food Policy Impact on the Overview and Update: Center for Food Safety and Applied Nutrition Initiatives
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the Institute of Food Technologists, American Society for Nutrition, and other guests from the food industry
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event